QUCY — Mainz Biomed NV Cashflow Statement
0.000.00%
Last trade - 00:00- $4.55m
- $6.23m
- $0.54m
Annual cashflow statement for Mainz Biomed NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 10-K |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.7 | -26.4 | -26.3 | -21.7 | -16.2 |
| Depreciation | |||||
| Non-Cash Items | 8.54 | 9.85 | 3.56 | 3.49 | 6.25 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.139 | 1.39 | -0.065 | 0.052 | -1.63 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.22 | -14.8 | -21.9 | -17.1 | -11 |
| Capital Expenditures | -0.017 | -0.658 | -1.9 | -0.255 | -1.05 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.22 | — | — | 0.056 | 0.018 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 1.2 | -0.658 | -1.9 | -0.199 | -1.03 |
| Financing Cash Flow Items | 0.244 | 0 | -0.934 | 0 | -0.243 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.6 | 23.9 | 14.2 | 16.6 | 6.76 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.6 | 8.41 | -10.1 | -0.835 | -5.35 |